Abstract:Selective inhibition of cancer cells remains a challenge in chemotherapy. Here we report the molecular and cellular validation of enzyme-instructed self-assembly (EISA) as a multiple step process for selectively killing cancer cells that overexpress alkaline phosphatases (ALPs). We design and synthesize two kinds of D-tetrapeptide containing one or two phosphotyrosine residues and with the N-terminal capped by a naphthyl group. Upon enzymatic dephosphorylation, these D-tetrapeptides turn into self-assembling molecules to form nanofibers in water. Incubating these D-tetrapeptides with several cancer cell lines and one normal cell line, the unphosphorylated D-tetrapeptides are innocuous to all the cell lines, the mono- and diphosphorylated D-tetrapeptides selectively inhibit the cancer cells, but not the normal cell. The monophosphorylated D-tetrapeptides exhibit more potent inhibitory activity than the diphosphorylated D-tetrapeptides do; the cancer cell lines express higher level of ALPs are more susceptible to inhibition by the phosphorylated D-tetrapeptides; the precursors of D-tetrapeptides that possess higher self-assembling abilities exhibit higher inhibitory activities. These results confirm the important role of enzymatic reaction and self-assembly. Using uncompetitive inhibitors of ALPs and fluorescent D-tetrapeptides, we delineate that the enzyme catalyzed dephosphorylation and the self-assembly steps, together, result in the localization of the nanofibers of D-tetrapeptides for killing the cancer cells. We find that the cell death modality likely associates with the cell type and prove the interactions between nanofibers and the death receptors. This work illustrates a paradigm shifting and biomimetic approach and contributes useful molecular insights for the development of spatiotemporal defined supramolecular processes/assemblies as potential anticancer therapeutics.

Enzyme-Regulated Supramolecular Assemblies of Cholesterol Conjugates against Drug-Resistant Ovarian Cancer Cells

Cancer‐Selective Supramolecular Chemotherapy by Disassembly‐Assembly Approach

Enzyme-instructed Assembly of a Cholesterol Conjugate Promotes Pro-Inflammatory Macrophages and Induces Apoptosis of Cancer Cells.

Enzyme‐Instructed Intracellular Molecular Self‐Assembly to Boost Activity of Cisplatin Against Drug‐Resistant Ovarian Cancer Cells

Rationally Designed Enzyme‐Resistant Peptidic Assemblies for Plasma Membrane Targeting in Cancer Treatment

A Ph‐activatable Copper‐Biomineralized Proenzyme for Synergistic Chemodynamic/Chemo‐Immunotherapy Against Aggressive Cancers

Enzymatic assemblies disrupt the membrane and target endoplasmic reticulum for selective cancer cell death

Cholesterol Depletion-Enhanced Ferroptosis and Immunotherapy via Engineered Nanozyme

pH‐Activatable Copper‐Biomineralized Proenzyme for Synergistic Chemodynamic/Chemo‐Immunotherapy against Aggressive Cancers

Nanozyme-natural enzymes cascade catalyze cholesterol consumption and reverse cancer multidrug resistance

Integrating Enzymatic Self-Assembly and Mitochondria Targeting for Selectively Killing Cancer Cells without Acquired Drug Resistance

A Biomimetic Nanoreactor for Combinational Chemo/chemodynamic Therapy of Choriocarcinoma Through Synergistic Apoptosis and Ferroptosis Strategy

Robust Dual Enzyme Cascade‐Catalytic Cholesterol Depletion for Reverse Tumor Multidrug Resistance

Cholesterol-directed Nanoparticle Assemblies Based on Single Amino Acid Peptide Mutations Activate Cellular Uptake and Decrease Tumor Volume

Enzyme-Instructed Self-Assembly Of Small D-Peptides As A Multiple-Step Process For Selectively Killing Cancer Cells

Integration of Enzymatic Transformation and Self‐Assembly for Future Cancer Therapy

Supramolecular amino acid-based metallo-nanozyme through multicomponent coordination self-assembly for in-site tumor synergistic catalytic-chemotherapy

Single-Site Nanozymes with a Highly Conjugated Coordination Structure for Antitumor Immunotherapy Via Cuproptosis and Cascade-Enhanced T Lymphocyte Activity.

Antitumor activity of endoperoxide-iron chelator conjugates―design, synthesis and biological evaluation

Self-assembling nanoparticles encapsulating zoledronic acid revert multidrug resistance in cancer cells

Combination Therapy to Overcome Ferroptosis Resistance by Biomimetic Self-Assembly Nano-Prodrug